KAYE RANDALL

PrivateCIK: 1350416
Location

SAN DIEGO, CA

KAYE RANDALL (CMO) sold 48.2% of their position (16.67K shares) of LONGBOARD PHARMACEUTICALS, INC. on the open market

Open‑market sale worth $527.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales
InsiderKAYE RANDALLCIK 1350416
Officer· CMO
Since Mar 2022
-16.67K
Net shares
Net seller
$527.3K
Total sold
4
Open market trades
0B · 4S
6
Total transactions
16.67K acquired · 33.33K disposed
Non-Derivative Transactions5

Common Stock

Direct
M · Option Exercise

Shares

+16.67K

Price / share

$4.35

Trade value

$72.50K

% of position

93.0%
9/16/2024
17.92K34.59K

Common Stock

Direct
S · Sale

Shares

9.37K

Price / share

$30.89

Trade value

$289.28K

% of position

27.1%
9/16/2024
34.59K25.22K

Common Stock

Direct
S · Sale

Shares

4.20K

Price / share

$31.81

Trade value

$133.62K

% of position

16.7%
9/16/2024
25.22K21.02K

Common Stock

Direct
S · Sale

Shares

1.20K

Price / share

$33.12

Trade value

$39.75K

% of position

5.7%
9/16/2024
21.02K19.82K

Common Stock

Direct
S · Sale

Shares

1.90K

Price / share

$34.04

Trade value

$64.67K

% of position

9.6%
9/16/2024
19.82K17.92K
Total

Net shares

+0.00

Net value

-$454.82K

Derivative Transactions1

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

16.67K shares

Shares

16.67K

Strike price

4.35

Held after

112.97K

Exercisable

9/16/2024
KAYE RANDALL — Insider Transaction (Form 4) Filed Sep 16, 2024 | Finecho